Novo CEO Says Investing Significantly in China

Aug. 19 (Bloomberg) -- Lars Rebien Soerensen, chief executive officer of Novo Nordisk A/S, talks about company growth and regulation of the pharmaceuticals industry. He speaks with Francine Lacqua and Manus Cranny on Bloomberg Television's "The Pulse." (Source: Bloomberg)

Oil Down for 3rd Week, OPEC Meets in Kuwait
36:39 - Oil headed for a third weekly drop this month, weighed down by record U.S. crude supplies while investors await a meeting between OPEC and its allies that may signal whether output curbs will be extended. Bloomberg's Yousef Gamal El-Din reports on "Bloomberg Markets." (Source: Bloomberg)
  • Merck KgaA, Pfizer Cancer Drug to Cost $13,000 a Month
  • Aviva's Diebel Sees No Macro Impact From Healthcare Bill
  • Italy Junior Minister Sees Brexit as EU Opportunity